All Stories

  1. Multimodality in liquid biopsy: does a combination uncover insights undetectable in individual blood analytes?

    Article • Journal of Laboratory Medicine, May 2022, De Gruyter

    Corinna Keup

  2. Combinatorial Power of cfDNA, CTCs and EVs in Oncology

    Article • Diagnostics, March 2022, MDPI AG

    Corinna Keup

  3. Integrative statistical analyses of multiple liquid biopsy analytes in metastatic breast cancer

    Article • Genome Medicine, May 2021, Springer Science + Business Media

    Corinna Keup

  4. Longitudinal Multi-Parametric Liquid Biopsy Approach Identifies Unique Features of Circulating Tumor Cell, Extracellular Vesicle, and Cell-Free DNA Characterization for Disease Monitoring in Metastatic Breast Cancer Patients

    Article • Cells, January 2021, MDPI AG

    Corinna Keup

  5. Circulating Tumor Cells Expressing the Prostate Specific Membrane Antigen (PSMA) Indicate Worse Outcome in Primary, Non-Metastatic Triple-Negative Breast Cancer

    Article • Frontiers in Oncology, September 2020, Frontiers

    Corinna Keup

  6. Abstract 5366: Metastatic breast cancer subgroup specific mRNA profiles of circulating tumor cells and extracellular vesicles

    Article • Cancer Research, August 2020, American Association for Cancer Research (AACR)

    Corinna Keup

  7. Molecular characterization of circulating tumour cells identifies predictive markers for outcome in primary, triple‐negative breast cancer patients

    Article • Journal of Cellular and Molecular Medicine, June 2020, Wiley

    Corinna Keup

  8. Multimodal Targeted Deep Sequencing of Circulating Tumor Cells and Matched Cell-Free DNA Provides a More Comprehensive Tool to Identify Therapeutic Targets in Metastatic Breast Cancer Patients

    Article • Cancers, April 2020, MDPI AG

    Corinna Keup

  9. Abstract P4-01-11: Circulating tumor cells expressing the prostate specific membrane antigen PSMA indicate worse outcome in triple-negative breast cancer patients at primary diagnosis

    Article • Cancer Research, February 2020, American Association for Cancer Research (AACR)

    Corinna Keup

  10. Abstract P5-01-14: The combined blood analysis of cell-free DNA and genomic DNA of circulating tumor cells reveals additive value in hormone receptor-positive, HER2-negative metastatic breast cancer patients

    Article • Cancer Research, February 2020, American Association for Cancer Research (AACR)

    Corinna Keup

  11. Liquid Biopsies to Evaluate Immunogenicity of Gynecological/Breast Tumors: On the Way to Blood-Based Biomarkers for Immunotherapies

    Article • Breast Care, January 2020, Karger Publishers

    Corinna Keup

  12. Abstract 1369: Establishment of a workflow for analysis of mRNA and gDNA from circulating tumor cells, extracellular vesicles and cell-free DNA from the same blood sample to mirror the genomic and transcriptomic complexity in metastatic breast cancer p...

    Article • Cancer Research, July 2019, American Association for Cancer Research (AACR)

    Corinna Keup

  13. Targeted deep sequencing revealed variants in cell-free DNA of hormone receptor-positive metastatic breast cancer patients

    Article • Cellular and Molecular Life Sciences, June 2019, Springer Science + Business Media

    Corinna Keup

  14. Cell-Free DNA Variant Sequencing Using CTC-Depleted Blood for Comprehensive Liquid Biopsy Testing in Metastatic Breast Cancer

    Article • Cancers, February 2019, MDPI AG

    Corinna Keup

  15. Abstract P4-01-10: The analysis of cell-free DNA and circulating tumor cells from one blood tube might empower treatment decisions in metastatic breast cancer patients

    Article • February 2019, American Association for Cancer Research (AACR)

    Corinna Keup

  16. Targeted PCR-based deep sequencing of cfDNA with unique molecular indices by a customized QIAseq Targeted DNA Panel v1

    Article • September 2018, ZappyLab, Inc.

    Corinna Keup

  17. Abstract 3650: Use of unique molecular identifiers to gain insight about the true positive mutations in cfDNA of breast cancer patients for implementation of personalized treatment

    Article • July 2018, American Association for Cancer Research (AACR)

    Corinna Keup

  18. RNA of Circulating Tumor Cells and Extracellular Vesicles in Metastatic Breast Cancer

    Article • Clinical Chemistry, May 2018, AACC

    Corinna Keup

  19. Molecular characterization of circulating tumor cells identifies predictive markers for outcome in triple-negative breast cancer patients

    Article • May 2018, Thieme Publishing Group

    Corinna Keup

  20. Abstract P2-01-06: Similarities and differences in RNA profiles of circulating tumor cells in breast cancer subtypes: Do we have therapeutic options?

    Article • February 2018, American Association for Cancer Research (AACR)

    Corinna Keup

  21. Application of dual reading domains as novel reagents in chromatin biology reveals a new H3K9me3 and H3K36me2/3 bivalent chromatin state

    Article • Epigenetics & Chromatin, September 2017, Springer Science + Business Media

    Corinna Keup

  22. Abstract 3777: RNA profiles of circulating tumor cells and extracellular vesicles for therapy stratification of metastatic breast cancer patients

    Article • July 2017, American Association for Cancer Research (AACR)

    Corinna Keup